Actively Recruiting

Early Phase 1
Age: 19Years - 80Years
All Genders
NCT05824338

Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery

Led by Fraser Health · Updated on 2024-10-08

45

Participants Needed

2

Research Sites

70 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this pilot clinical trial is to test the feasibility of conducting a randomized controlled trial that will examine the use of ropivacaine in the spinal anesthesia for patients undergoing elective 1- or 2-level lower spine surgery. This study aims to: * Determine the rates of eligibility, recruitment, consent, and attrition * Determine the acceptability among patients, surgeons, anesthesiologists, and nurses of doing spine surgery under spinal anesthesia * Gather preliminary data on outcomes relevant to a future dose-finding study Participants will be randomized to one of three treatment groups: * General anesthesia with endotracheal tube * Spinal anesthesia with bupivacaine * Spinal anesthesia with ropivacaine

CONDITIONS

Official Title

Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery

Who Can Participate

Age: 19Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients who are equal to or greater than 18 years old
  • Undergoing elective one or two-level lumbar surgery via posterior surgical approach in the prone position (between L2-S1)
  • Expected surgery duration of no greater than 2 hours
  • ASA Physical Status Class 1 to 3
  • Patient can have either spinal anesthesia or general anesthesia
  • Able to provide consent and understand information in English, and capable of answering questions in English
Not Eligible

You will not qualify if you...

  • Allergy to either ropivacaine, bupivacaine, or local anesthetics
  • Contraindications to spinal anesthesia (i.e. coagulopathy or on anticoagulants, severe aortic or mitral valve stenosis, sepsis or bacteremia, thrombocytopenia, high intracranial pressure, infection at the puncture site)
  • Surgery is expected to take more than 2 hours
  • Emergency surgery
  • Previously had back surgery at the level of the spine currently being operated on
  • Comorbidities that require the patient to undergo general anesthesia
  • Inability to stay still during the surgery
  • Inability to move legs preoperatively
  • Body Mass Index (BMI) >35
  • Multilevel severe spinal stenosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Royal Columbian Hospital

New Westminster, British Columbia, Canada, V3L 3W7

Not Yet Recruiting

2

Eagle Ridge Hospital

Port Moody, British Columbia, Canada, V3H 3W9

Actively Recruiting

Loading map...

Research Team

M

Michelle Mozel, MSc.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here